Open Orphan signs deal to carry out Covid-19 vaccine trial

Dublin listed company will carry out phase one trial at Hvivo facility

Open Orphan executive chairman Cathal Friel.

Open Orphan executive chairman Cathal Friel.

Dublin-listed pharmaceutical services company Open Orphan has signed a new deal with New York-based Codagenix for the phase one trial of a new Covid-19 vaccine.

The trial, which will evaluate the safety and ability of the vaccine to evoke a repulsions in the immune system, will look at 48 healthy young adult volunteers.

Please subscribe or sign in to continue reading.
only €1 first month

Insightful opinion is just a away.